[Corrigendum] Sulforaphane suppresses the viability and metastasis, and promotes the apoptosis of bladder cancer cells by inhibiting the expression of FAT‑1

Int J Mol Med. 2022 Jul;50(1):93. doi: 10.3892/ijmm.2022.5149. Epub 2022 May 26.

Abstract

Following the publication of the above paper, the authors drew the Editor's attention to the fact that their article contained two textual errors located in the same sentence: In the 'Sample collection' subsection of the Materials and methods section on p. 1086 (the first sentence), the text here should have read as follows (changes highlighted in bold): 'In the present study, 85 bladder cancer tissues and 27 adjacent normal tissues were collected from patients with BC who attended the Bao'an Central Hospital of Shenzhen and Shenzhen Hospital of Southern Medical University between 2014 and 2018 for treatment.' (i.e. the samples were not exclusively collected from the Shenzhen Hospital of Southern Medical University as stated, and the collection dates should have been written as 2014 and 2018, not as 2010 and 2014). The authors are grateful to the Editor of International Journal of Molecular Medicine for allowing them the opportunity to publish this Corrigendum, and they apologize for any inconvenience caused to the readership of the Journal. [International Journal of Molecular Medicine 46: 1085‑1095, 2020; DOI: 10.3892/ijmm.2020.4665].

Keywords: FAT atypical cadherin 1; bladder cancer; metastasis; sulforaphane; viability.

Publication types

  • Published Erratum